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A B S T R A C T
Mesenchymal stem cells (MSC) are heterogeneous cells of complex nature that show different potentials while
different culture conditions can modify their functionalities through interactions with the microenviroment.
Here, we found that bone marrow (BM) MSC from different donor sources and passages that expressed higher
levels of α6 integrin subunit (ITGA6), showed higher clonogenicity, migration and differentiation potential.
ITGA6 showed important roles improving these potentials and regulating proliferation through protein kinase B
(AKT) pathway and cell cycle inhibitor proteins p53 and p21. Moreover, ITGA6 downregulation impaired mi-
gration. Cell confluence regulated ITGA6, increasing its expression in low density cultures and decreasing in high
density cultures. Besides, ITGA6- cells expressed ITGA6 when seeded at low densities. We found higher ITGA6
expression on fibronectin substrates at lower confluency. Fibronectin increased proliferation, clonogenicity,
activation of AKT, decreased cell cycle inhibitor proteins and augmented growth factors expression. Spheres-
derived MSC showed higher ITGA6 expression and enhanced potentials for migration, clonogenicity and pro-
liferation. In conclusion, though there is an intrinsic regulation of ITGA6 expression, associated to the progenitor
potential of BM-MSC, this expression is regulated by culture conditions and is translated in changes in cell
behavior and proliferation. This knowledge could be used to enhance the potential of BM-MSC for clinical
application.
1. Introduction
Mesenchymal stem cells (MSC) have emerged as a promising tool for
tissue engineering because their capability to differentiate toward
various lineages (Liu et al., 2009). These cells are also accessible so-
matic stem cells that can be easily isolated. Consequently, several
clinical trials use MSC in disorders that need organ or tissue re-
generation. This is the case of osteogenesis imperfecta, bone fractures,
heart infarction, autoimmune disorders or graft-versus-host disease
(Squillaro et al., 2016).
MSC are defined by plastic adherence, multilineage differentiation
potential and a mesenchymal phenotype (Dominici et al., 2006). The
phenotypic identification of MSC is based on the expression of CD73,
CD90 and CD105 among other markers (Dominici et al., 2006) but none
of these markers could identify progenitor phenotypes. However, MSC
are a heterogeneous population of cells with different capabilities
(Colter et al., 2001) and MSC from different donors or somatic sources
can have different capacities (Alt et al., 2012; Zaim et al., 2012; Zhu
et al., 2009). These issues can affect therapeutic results. So, it is ne-
cessary the search for markers that could distinguish the early pro-
genitors of these cells and increase the knowledge of the intrinsic and
extrinsic mechanisms modulating MSC progenitor behavior. Therefore,
the characterization of optimal culture conditions to enhance the po-
tential of MSC is of great significance.
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Stem cells are directed by the extracellular microenvironment,
which modulates their self-renewal and differentiation. This requires a
close interaction between stem cells and the signals arising from the
niche (Bara et al., 2014). In this sense, integrins binding to extracellular
matrix proteins can modulate stem cell behavior (Frith et al., 2012).
Integrin alpha 6 (ITGA6) expression is conserved among different po-
pulations of stem cells, such as embryonic stem cells, epithelial intestine
stem cells, neural stem cells and some MSC (Krebsbach and Villa-Diaz,
2017), and plays important functions regulating self-renewal (Villa-
Diaz et al., 2016) and stemness (Lee et al., 2009; Yu et al., 2012). The
interaction between microenvironmental signals and intrinsic cell cues
are necessary for the preservation of progenitor potential and any
shortcoming in this interaction is linked to a decrease in this potential.
Increasing the knowledge between extrinsic and intrinsic cues would
allow to improvements in the regenerative potential of MSC for cell
therapy.
In this research, we aimed to determine whether the expression of
ITGA6 could be modified extrinsically and whether this fact can influ-
ence the progenitor behavior of BM-MSC. To do so, we first considered
the intrinsic expression of ITGA6 in MSC from different donor sources
among passages and evaluated the implications of this integrin on
proliferation, differentiation, migration and clonogenicity. Then, we
studied the extrinsic modulation of ITGA6 expression through different
substrates in low- and high-density cultures, exploring the impact in cell
behavior. Finally, we explored a strategy to increase the expression of
ITGA6 and the potentials of MSC for cell therapy using MSC spheroids.
Our results suggest the existence of not only an intrinsic regulation of
ITGA6 associated to the progenitor potential, but also a micro-
environmental regulation of ITGA6 expression, that is translated in a
modulation of cell cycle proteins, proliferation, differentiation, migra-
tion and clonogenicity.
2. Materials and methods
2.1. Ethical considerations
This study followed the ethical precepts of the Declaration of
Helsinki (Fortaleza, Brazil, Oct 2013) and was approved by local ethics
committee (CEIC, Hospital Clinic de Barcelona; Ref 7365-12). Human
samples were processed according to guidance for clinical use (EEC
regulations 2004/23/CE and 2006/17/CE) and to the legal require-
ments Spain (Law 14/2007, RD 1716/2011 and RD 9/2014). Samples
were obtained under informed consent. The use of personal data com-
plied with local regulations (Law/05/2018).
2.2. Isolation and culture of cells
BM-MSC were obtained by iliac crest bone marrow aspiration, and
transmissible infections were excluded by serologic analyses. BM-MSC
were isolated, as described elsewhere (Rider et al., 2008). BM-MSC
were cultured in MSC medium comprising α minimum essential
medium with GlutaMAX™ (αMEM-GT, Invitrogen, Carlsbad, CA) sup-
plemented with non-inactivated 10% fetal calf serum (FCS, Invitrogen)
and 1% antibiotics and maintained in 5% CO2 at 37 °C. Same numbers
of cells per donor were pooled at passage 1. Cells from 5 live healthy
donors at passage 3 or 4 were used for experiments. When indicated, 3
different donor sources were used: alive healthy (a-MSC), cadaveric
heart arrest (ha-MSC), and cadaveric encephalic death donors (ed-
MSC). Isolation, culture, and characterization of adipose tissue MSC
(AT-MSC) was showed previously (Martínez-Conesa et al., 2012).
Doubling population time was calculated as described before (Piera-
Velazquez et al., 2002). Induced pluripotent stem cells (IPSC) were
kindly gifted by Angel Raya and used for qPCR experiments.
2.3. Spheroid and spheroid-derived MSC generation
For sphere formation, BM-MSC from healthy donors at passage 3–4
were plated at low density in ultralow-adherence 35 mm dishes
(Invitrogen) in spheroid formation medium composed of DMEM/F12
(1:1)/ human endothelial serum-free medium (1:2) (Invitrogen), 15%
chicken embryo extract (Seralab, Huissen, Netherland), 0.1 mM β-
mercaptoethanol (Sigma), 1% nonessential amino acids (Sigma), 1% N2
and 2% B27 supplements (Invitrogen), 20 ng/ml recombinant human
fibroblast growth factor (FGF)-basic, 20 ng/ml recombinant human
epidermal growth factor (EGF), 20 ng/ml recombinant human platelet-
derived growth factor (PDGF-AB), 20 ng/ml recombinant human on-
costatin M (227 aa OSM, 20 ng/ml) and 40 ng/ml recombinant human
IGF-1 (all supplements from Peprotech) and maintained as described
(Isern et al., 2013). To generate spheroid-derived MSC, the MSC
spheroids were seeded with MSC medium in adherent conditions,
grown to the end of the passage, trypsinized, and used for experiments.
2.4. Multilineage differentiation experiments
Differentiation experiments were performed as described before
(Mosna et al., 2010). Adipogenesis was performed with adipogenic
induction medium containing Dulbecco's Modified Eagle's Medium 1 g/
l (DMEM, Invitrogen) supplemented with 0.5 mM isobutyl methyl-
xanthine (Sigma-Aldrich, Munich, Germany), 1 µM dexamethasone
(Sigma-Aldrich), and 200 µM indomethacin (Sigma-Aldrich) and con-
firmed at 28 days by Oil-Red-O staining, eluted with 100% isopropanol.
Osteogenic induction was performed in DMEM 1 g/l medium with 1 µM
dexamethasone, 50 µg/mL ascorbic acid (Sigma-Aldrich), and 10 mM
glycerol 2-phosphate (Sigma-Aldrich) and confirmed at 28 days by
Alizarin Red staining, eluted with 10% cetylpyridinium chloride. Cells
(2 × 105 cells/cm2) were pelleted and chondrogenic induction was
performed adding DMEM 1 g/l supplemented with 0.4% insulin-trans-
ferrin-selenium (ITS, Sigma-Aldrich), 350 µM L-proline (Sigma-Al-
drich), 170 nM ascorbic acid, 1 mM sodium pyruvate (Lonza, Verviers,
Belgium) and 10 ng/ml transforming growth factor-beta 1 (TGF-β1,
Sigma-Aldrich) for 28 days. After that, pellets were fixed with 4%
paraformaldehyde for 1 h at room temperature, stained with Alcian
Blue, embedded in paraffin, and sectioned at thicknesses of 5 µm.
2.5. Flow cytometry characterization and sorting
Cells were blocked with 10% FCS for 10 min and incubated for
30 min at room temperature with conjugated antibodies (Table S1).
Samples were analyzed by FACS (Calibur Flow Cytometer, BD Bios-
ciences, San José, CA, USA) and data were evaluated by Summit version
3.1 software (Cytomation, Fort Collins, CO, USA). ITGA6 analysis was
performed at the end of the passages, unless indicated and size analysis
was performed as described before (Romano et al., 2003). Sorting was
performed in a FACS Aria Fusion cell sorting cytometer (BD Bios-
ciences), and post-sorting vitality testing was done with trypan blue to
ensure equal survival of the sorted populations. Mouse monoclonal IgG
isotype antibody was used as a negative control (Table S1). To assay the
influence of different substrates on ITGA6 expression, cells were seeded
at a density of 1,000 cells/cm2 on either fibronectin at 10 µg/mL (FN,
Sigma-Aldrich), laminin-111 at 20 µg/mL (LN, Sigma-Aldrich, L2020,
www.sigmaaldrich.com/catalog/product/sigma/l2020?lang=es&
region=ES) or plastic. Cells were grown for 24 h (D + 1, low density)
or 7 days (D + 7, high density). Cells were then trypsinized and subject
to flow cytometry and clonogenic assay.
2.6. Colony forming efficiency assay
For clonogenic experiments, 10 cells/cm2 were seeded in 35 mm
diameter plates and cultured in MSC medium for 14 days. After that,
cells were stained with 0.5% crystal violet. Colonies were scored
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according to (Sotiropoulou et al., 2006). To test the influence of dif-
ferent substrates on the colony forming efficiency (CFE) potential, cells
were seeded as described above.
2.7. Adhesion assay
For adhesion assays, 96 well plates were coated with specific ex-
tracellular adhesion proteins, FN at 10 µg/ml, LN at 20 µg/ml or bovine
serum albumin (BSA, Sigma) at 10 µg/ml as a control. We seeded 104
cells/cm2 on coated plates in MSC medium. After the indicated time,
wells were stained with 0.5% crystal violet, washed, air dried, and
eluted with 33% acetic acid solution. Absorbance was measured with
Tecan Infinite m200 pro (Tecan, Mannedorf). To test whether ITGA6
blocking could affect adhesion to the substrates, 5 × 103 cells were
seeded with 10 µg/mL of an ITGA6 neutralizing antibody (Table S1) on
the coated or uncoated 96-well plates, and adhesion assay was per-
formed at 60 min. A mouse monoclonal IgG (Table S1) was used as a
control.
2.8. Migration assay
Cell migration was analyzed using 24-well inserts with 8 µm pore
size fluorescence blocking membranes (Corning, MA, USA) on 24-well
plates. Cells were seeded in serum free medium (DMEM 1 g/l medium)
in the insert. Culture medium with 10% FCS was added to the lower
well and incubated for 20 h. The cells that migrated through the insert’s
membrane were stained using 5 µM Calcein (Molecular Probes™,
Invitrogen) and their fluorescence was detected at an excitation of
480 nm and an emission of 530 nm (Tecan Infinite m200 pro). Cell
migration was normalized to controls and expressed as a percentage of
migration. The migrated cells were photographed in an epifluorescence
microscope (BX61; Olympus R-FTL-T; Olympus America Inc., Center
Valley, PA, USA), using the digital image acquisition program (Olympus
DP Controller).
2.9. Proliferation assay
Proliferation was assayed by seeding 104 cells/cm2 on 96 wells in
MSC medium, and a bromodeoxyuridine assay (BrdU) was added 24 h
after cell seeding at a final concentration of 1 mM. After 2 h, DNA
synthesis was assayed with the Cell Proliferation ELISA BrdU kit (Roche
Molecular Biochemicals, Mannheim, Germany), according to manu-
facturer’s instructions.
2.10. Small interfering mRNA transfection
To inhibit ITGA6 specifically, a small interfering mRNA (siRNA)
knockdown assay was performed using a commercial ITGA6-targeting
siRNA (sc-43129, Santa Cruz, CA, USA) with an unspecific siRNA
(siCTL, sc-37007, Santa Cruz, CA, USA). The transfections were per-
formed using Lipofectamine (Invitrogen) according to the manufacturer
instructions. Briefly, cells were seeded at a density of 15,000 cells/cm2,
incubated with 2 µM siRNA, and lysed with a western blot loading
buffer 72 h after transfection to evaluate protein expression.
2.11. Immunofluorescence and confocal microscopy
Cells grown on glass coverslips were fixed with 4% paraformalde-
hyde, permeabilized, and blocked. Coverslips were then incubated with
primary antibodies for 16 h at 4 °C in a humidified chamber. After
washes, proper secondary antibody was added for 60 min at 37 °C in a
humidified chamber. The coverslips were mounted upside down with
mounting medium (Vectashield, Vector Laboratories, CA, USA) and the
nuclei were counterstained with DAPI (4′,6-diamidino-2-phenylindole).
Cells were observed in an epifluorescence microscope. For confocal
microscopy with MSC spheroids, spheres were treated as described
above. Hoechst 33,342 (Sigma) was used for nucleus staining. Samples
were mounted with Fluoromount (Sigma) and images were captured
using a TCS SP2 Leica confocal laser scanning microscope (Leica
Lasertechnick GmbH, Mannheim, Germany). Antibodies used are de-
tailed in Table S1.
2.12. Western blot analysis
Western blot was performed as described before (Piera-Velazquez
et al., 2002). Protein bands were revealed using an enhanced chemi-
luminescence substrate (Biological Industries, Reactiva, Barcelona,
Spain) and recorded on autoradiography film (Kodak Rochester, NY,
USA). Western blots were analyzed by digitally scanning the blots, and
followed by densitometric analysis using ImageJ as indicated (Rasband,
2012). All analyses were normalized to a tubulin loading control, ex-
cept for phosphorylated protein kinase B (p-AKT), which was normal-
ized to the total AKT.
2.13. Extraction of mRNA and quantitative polymerase chain reaction
Total RNA was extracted from cells using a PureLink RNA Mini Kit
(Ambion, Invitrogen), following manufacturer’s instructions. The RNA
concentration was measured using the Tecan Infinite m200 Pro, and
1 μg RNA was reverse-transcribed using Superscript III (Invitrogen),
according to the manufacturer’s instructions. Then, 0.5 μL of cDNA was
used for quantitative polymerase chain reaction (qPCR) in a final vo-
lume of 18 μL with SYBR Green Reaction Mix (Invitrogen) and a 0.2 μM
primer concentration. We performed qPCR using the Step One (Applied
Biosystems, Life technologies, Glasgow, UK) hardware and software.
The expression levels of target genes were normalized to internal 18 s
(rrn18s, Tataa Biocenter, Sweden) and presented as relative expressions
based on the 2-ΔΔCt formula. Sequences and annealing temperatures of
PCR primers are listed in Table S2.
2.14. Statistical analysis
Experiments were performed at least in triplicate. Two-tailed
Student’s t-tests were used for comparisons. Correlations were assessed
using Kendall correlation coefficient (τ). Values of p<0.05 were con-
sidered statistically significant. The R software, (R Development Core
Team, 2012) was used. All results are presented as the mean ±
standard error (MD ± SE).
3. Results
3.1. ITGA6 was related to higher clonogenicity and migration but was lost
with culture passages
We first focused our attention on testing the intrinsic potentials of
BM-MSC from distinct donor sources for clonogenicity, migration and
ITGA6 expression at the end of different passages during amplification
to determine whether ITGA6 could correlate with these potentials.
The highest ITGA6 expression was found in a-MSC and ha-MSC at
passage number (P) 1, while ed-MSC showed the lowest expression. In
all cases, ITGA6 levels decreased at P5 though a-MSC and ha-MSC
shared similar expression levels and ed-MSC showed again the lowest
expression (Fig. 1A). CFE assays at P1 revealed that a-MSC had the
highest clonogenic capacity, followed by ha-MSC, whereas the ed-MSC
showed the lowest capacity. CFE decreased with the passage number in
all cases (Fig. 1B). However, a-MSC continued to exhibit higher CFE
than ha-MSC while ed-MSC showed the lowest CFE at P5. To further
study the correlation between ITGA6 expression and clonogenicity, we
studied MSC from aged passages and other sources. So, we analyzed a-
MSC at P9 and AT-MSC at P1 for CFE and ITGA6 expression (Fig. S1).
Both presented insignificant CFE results that correlated with a very low
expression of ITGA6. Kendall coefficient showed a strong correlation
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between CFE and ITGA6 expression in all analyzed conditions
(τ = 0.71; p = 0.003) (Fig. S2).
Regarding migration, results showed similar patterns to those for
CFE, decreasing with passage number. At P1, a-MSC and ha-MSC
showed the highest percentages of migration, without significant dif-
ferences, whereas ed-MSC group had the lowest percentage of migra-
tion. Thus, a-MSC and ha-MSC reduced its migration at P5, although ha-
MSC highly reduced their potential. The percentage values of migration
in ed-MSC were again the lowest (Fig. 1C).
3.2. MSC could retain mesenchymal phenotype although showed impaired
clonogenicity or migration
Next, to demonstrate the maintenance of mesenchymal phenotype,
Fig. 1. ITGA6 expression, clonogenic and cell migration potential of BM-MSC from different sources. (A) Expression of ITGA6 + at passage 1 (P1) and 5 (P5) and
isotype negative control (Neg). (B) Colony forming efficiency (CFE) assay at P1, P5. (C) transwell migration assays using calcein staining and the percent of migrated
cells at P1 and P5 (Bar = 50 μm). BM-MSC from alive healthy (a-MSC), heart arrest (ha-MSC), and encephalic death (ed-MSC) donors. Results are presented as
mean ± SE from 3 independent experiments. Statistical analysis was performed using two-tailed Student’s t-tests (*, p < 0.05; **, p < 0.01; ***, p < 0.001 P1
compared to P5; ##, p < 0.01; ###, p < 0.001 compared to a-MSC P1; &, p < 0.05 compared to a-MSC).
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we performed trilineage differentiation and phenotypic analysis for the
MSC that were analyzed before for ITGA6 expression, CFE and migra-
tion at different passages.
All groups (a-, ed-, ha-MSC) successfully differentiated to osteo-
genic, adipogenic, or chondrogenic lineages during amplification up to
P5, although there were differences in the differentiation potential
(Fig. 2). Adipogenesis and osteogenesis were higher in a-MSC, followed
by ha-MSC and ed-MSC had the lowest differentiation capacity at P1.
Moreover, adipogenesis decreased through amplification while osteo-
genic differentiation was enhanced at P5. However, chondrogenesis and
adipogenesis failed at P8/10. Further, the phenotypic characterization
was maintained up to P5 in a-MSC. In the cadaveric donors, phenotypic
characterization was lost at P5 (Table S3).
3.3. ITGA6 selected smaller BM-MSC with greater proliferation,
clonogenicity and differentiation potentials
Then, we decided to check whether ITGA6 could be related to BM-
MSC potentials. So, cell sorting assays or function-blocking antibodies
were used to analyze proliferation, clonogenicity, differentiation and
migration.
Sorted ITGA6 + cells showed increased proliferation compared
with the ITGA6− fraction (Fig. 3A). In addition, ITGA6+ cells showed
augmented CFE and increased osteogenic and adipogenic differentia-
tion potential (Fig. 3C–D). Moreover, ITGA6 function-blocked cells with
specific antibodies presented reduced migration (Fig. 3F). Besides, we
used flow cytometry to determine the differences in cell size of both
fractions, showing that ITGA6 + cells were smaller than ITGA6 − cells
(Fig. 3B).
3.4. Culture confluence regulated ITGA6 affecting proliferation
Next, we aimed to study the extrinsic modulation of ITGA6.To ex-
plore the effects of culture confluence on proliferation and ITGA6 ex-
pression, we purified ITGA6 + cells and ITGA6- cells by cell sorting,
seeded them and compared them with unsorted cells. Then, we ana-
lyzed ITGA6 expression at 48 h and 168 h post-seeding. We also eval-
uated cell cycle proteins p53, p21 and the AKT pathway and calculated
the doubling population time (DPT). To further explore the relationship
between ITGA6 and cell cycle proteins, we performed mechanistic
siRNA ITGA6 inhibition assays and analyzed the effects on cell cycle
proteins.
At 48 h, almost all ITGA6 + fraction-derived cells expressed ITGA6
(Fig. 4A), while the unsorted cells expressed lessened ITGA6 expression.
The ITGA6 + fraction-derived cells showed a very weak expression of
p53 and p21 cell cycle inhibitor proteins and an increased proportion of
the growth associated signal transduction pathway p-AKT (Fig. 4B).
This correlated with decreased doubling population times (DPT), in-
dicating higher proliferation (Fig. 4D). ITGA6- fraction-derived cells
expressed ITGA6 although these levels were lower than in unsorted
cells. ITGA6- fraction-derived cells showed the lowest AKT activation
and the greatest increase of p53 and p21 (Fig. 4B), which correlated
with higher DPT, indicating lower proliferation (Fig. 4D).
The expression of ITGA6 decreased with culture time in all the si-
tuations at 168 h, although ITGA6 + fraction-derived cells expressed
higher levels of ITGA6, while ITGA6- fraction-derived cells expressed
lower levels (Fig. 4A). At 168 h, the expression of p53, p21 and the AKT
pathway were not different between all the situations (Fig. 4C). Al-
though the DPT remained lower in the ITGA6 + fraction-derived cells,
the DPT increased in all the situations in comparison with the DPT at
48 h (Fig. 4D). Collectively, these results showed a reduction in the
proliferation until the end of the assay.
ITGA6 inhibited cells increased the expression cell cycle proteins
p21, p27 and p53 (Fig. 4E). Accordingly, p-AKT was hindered, de-
monstrating the effect of ITGA6 on proliferation and supporting pre-
vious results (Fig. 3A).
3.5. Fibronectin enhanced more ITGA6 expression and CFE than laminin-
111 at low densities
Then, to assay the possible influence of substrates on ITGA6, we
assessed the changes in ITGA6 expression, CFE and migration induced
by fibronectin or laminin-111 under different confluency conditions.
At day 1 (D + 1), cells seeded at low confluency on fibronectin
expressed higher ITGA6 levels than either laminin-111 or controls as
showed by flow cytometry (Fig. 5A and B) and immunofluorescence
(Fig. 5C). There was an important reduction in ITGA6 expression 7 days
after culture (D + 7) in all the situations. In fact, cells grown on fi-
bronectin or laminin-111 showed more reduced ITGA6 expression than
controls (Fig. 5A–C).
Cells seeded on fibronectin at low confluence demonstrated the
highest CFE when reseeded on plastic (Fig. S3). BM-MSC grown on
laminin-111 and fibronectin after 7 days led lesser CFE compared with
controls. When examining the changes in cellular migration induced by
confluence, cells had impaired migration at D + 7 compared with the
cells seeded at D + 1 at lower confluence (Fig. S3).
3.6. Fibronectin improved more proliferation than laminin-111 activating
AKT pathway
The influence of substrates was further studied testing cell pro-
liferation on both laminin-111 and fibronectin at different times (24, 48
and 72 h) by BrdU incorporation assays and cell cycle proteins analysis.
Increased proliferation was seen at 24 h after the seeding, but the
most enhanced proliferation was detected in cells grown on fibronectin,
followed by those seeded on laminin-111 in comparison with controls
(Fig. 6A). Surprisingly, the lowest p-AKT expression was detected on
laminin-111 substrates (Fig. 6B). There was an increase in the propor-
tion of p-AKT on fibronectin, indicating activation of the AKT pathway
followed by controls. However, p21, p27, and p53 expressions were
decreased on both laminin-111 and fibronectin compared with controls.
Again, the lowest p21 and p27 expressions were found on fibronectin
substrates, corroborating the BrdU incorporation results (Fig. 6B).
3.7. Laminin-111 was more specific for ITGA6 binding although fibronectin
enhanced the expression of growth factors
To further understand the effects of substrates, we assayed the
specificity of ITGA6 for binding laminin-111 or fibronectin and ana-
lyzed the migration of MSC towards these substrates. Moreover, we
explored the mRNA expression of growth factors that could affect cell
adhesion, proliferation, and migration.
Fig. 2. Multi-lineage differentiation potential of BM-MSC from different sources. (A) In vitro adipogenesis differentiation at passage 1 (P1), 5 (P5) and 8–10 (P8/10)
(Bar = 50 μm) and Oil Red staining elution quantification. (B) In vitro osteogenesis differentiation at P1, P5 and P8/10 (Bar = 50 μm) and Alizarin Red staining
elution quantification. (C) In vitro chondrogenesis differentiation stained with Alcian Blue at P1, P5 and P8/10 (Bar = 200 μm). (D) Culture control conditions for
adipogenesis and osteogenesis differentiation (Bar = 50 μm). BM-MSC from alive healthy (a-MSC), heart arrest (ha-MSC), and encephalic death (ed-MSC) donors.
Results are presented as mean ± SE from 3 independent experiments. Statistical analysis was performed using two-tailed Student’s t-tests (*, p < 0.05 treated
compared to respective untreated controls in the same passage; &, p < 0.05 treated P1 compared to treated a-MSC at P1; ##, p < 0.01; ###, p < 0.001 treated
P5 compared to respective treated P1; %, p < 0.05 ed-MSC P5 compared to a-MSC P5; $, p < 0.05 treated P8/10 compared to respective treated P5; ?, p < 0.5
treated P8/10 compared to treated a-MSC at P8/10).
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Fig. 3. ITGA6 expression and proliferative potential. (A) Analysis of proliferation between ITGA6 + and ITGA- sorted cells by bromodeoxyuridine (BrdU) in-
corporation assay. (B) Size analysis of ITGA6 + and ITGA6- sorted cell cultures by flow cytometry. (C) Colony forming efficiency (CFE) of ITGA6 + and ITGA6-
sorted cell cultures. (D) In vitro adipogenesis differentiation and Oil Red staining elution quantification of ITGA6 + and ITGA6- sorted cell cultures. (E) In vitro
osteogenesis differentiation and Alizarin Red staining elution quantification of ITGA6 + and ITGA6- sorted cell cultures. (F) Percent of migrated cells using ITGA6
blocking antibody compared to control cells (IgG isotype) using through transwell migration assays. Cells stained with (Bar = 50 μm). Results are presented as
mean ± SE from 3 independent experiments. Statistical analysis was performed using two-tailed Student’s t-tests (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
N. Nieto-Nicolau, et al. Stem Cell Research 47 (2020) 101899
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Cell adhesion on laminin-111 decreased at every time point (10, 20,
30, and 60 min) (Fig. 6C), while adhesion on fibronectin increased at
10 min and 30 min. Using an ITGA6 function-blocking antibody, cell
adhesion was lowered on the laminin-111 substrate, indicating a spe-
cific participation of laminin-111 binding in MSC (Fig. 6E). Improved
migration from the apical to the basal side was observed on both the
laminin-111 -and fibronectin-coated inserts (Fig. 6F).
The mRNA expressions of epidermal growth factor receptor (EGFR),
transforming growth factor β (TGF-β), matrix metalloproteinase 2
(MMP2), and interleukin 6 (IL-6) increased in cells seeded on fi-
bronectin for 24 h (Fig. 6D). Only MMP2 and IL-6 expressions were
increased in cultures grown on laminin-111 for 24 h.
3.8. Spheroid-derived MSC presented higher ITGA6 expression,
proliferation, greater p-AKT activation and improved progenitor markers
expression
Finally, we explored a strategy to increase MSC potentials. To do so,
Fig. 4. ITGA6 regulation by culture confluence. (A) Sorting of both ITGA6 + and ITGA6- fractions by flow cytometry and the percent of ITGA6 of the both fractions
and unsorted cells (CTL) after seeding them for 48 h and 168 h. (B) Western blot analysis and quantification for cell cycle proteins p53, p21 and AKT signaling
pathway at 48 h after seeding. (C) Western blot analysis and quantification for cell cycle proteins p53, p21 and AKT signaling pathway at 168 h after seeding. (D)
Doubling cell population times (DPT) of ITGA6+, ITGA6- and CTL after being seeded for 48 h and 168 h. (E) Western blot analysis for cell cycle proteins and AKT in
small interference mRNA transfected cells for ITGA6 inhibition (siITGA6), compared to control cells transfected with unspecific interference mRNA (siCTL). Results
are presented as mean ± SE from 3 to 4 independent experiments. Statistical analysis was performed using two-tailed Student’s t-tests (*, p < 0.05; **, p < 0.01;
***, p < 0.001).
Fig. 5. ITGA6 expression on different substrates and the effects of culture confluence. (A–B) ITGA6 expression in BM-MSC by FACS on the different substrates at low
(D + 1) and high (D + 7) confluence cell culture conditions. Isotype negative controls (Neg). (C) Immunofluorescence for ITGA6 staining in BM-MSC on Ctl, LN and
FN at low (D + 1) and high (D + 7) confluence (Bar = 20 μm). Results are presented as mean ± SE from 3 independent experiments. Statistical analysis was
performed using two-tailed Student’s t-tests (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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we generated spheroids under non-adherent conditions, seeded them
(spheroid-derived MSC), analyzed the expression of ITGA6 and their
capacities using as controls monolayer cultured MSC at the same pas-
sage (Ctl). In these experiments we evaluated the migration potential,
the proliferation, the clonogenicity and the mRNA expression levels of
SOX2, OCT4 and NANOG. Since MSC express low or negligible levels of
Sox2 and Oct4 (Han et al., 2014; Matic et al., 2016; Pierantozzi et al.,
2011), we hypothesized that any increase in these pluripotency factors
could be linked to a higher progenitor state (Boiani and Schöler, 2005;
Orkin et al., 2008). IPSC were used for comparison.
Spheroid-derived MSC expressed more ITGA6 than monolayer-de-
rived MSC at the same passage (Fig. 7A). Moreover, the spheroid-de-
rived MSC showed increased CFE, migration potential, and improved
proliferation (Fig. 7B–D). Thus, the highest levels of p-AKT were pre-
sent in MSC spheroids followed by spheroid-derived MSC (Fig. 7E).
Proliferating cell nuclear antigen (PCNA) was higher in spheroid-de-
rived MSC and MSC spheroids and cell cycle inhibitor protein p27 was
downregulated in both conditions. Moreover, a marked upregulation in
the mRNA expression levels of the SOX2, OCT4 and NANOG were noted
in MSC spheroids (Fig. 7F). MSC spheroids expressed similar levels of
SOX2 and NANOG than those expressed by IPSC, although IPSC showed
higher expression of OCT4. Spheroid-derived MSC downregulated the
expression levels of the pluripotency factors, though retained higher
expression of OCT4 and SOX2 than the controls, monolayer cultured
MSC. However, spheroid-derived MSC showed lower levels of NANOG.
Increases in Sox2 and Oct4 could be also noticed in spheroid-derived
MSC compared with controls in representative micrographs by im-
munofluorescence (Fig. 7G).
4. Discussion
In this study, we showed that ITGA6 expression is associated to
intrinsic progenitor potentials and that could be upregulated ex-
trinsically by cell culture microenvironment, improving the prolifera-
tion, migration and clonogenicity while activated AKT pathway and
decreased cell cycle inhibitor proteins.
CFE is a widely accepted assay for quantifying the number of pro-
genitor cells in MSC cultures (Cordeiro-Spinetti et al., 2014) and for
predicting the replicative potential (Digirolamo et al., 1999). BM-MSC
with higher CFE, migration and differentiation potentials were those
expressing more ITGA6, and those potentials as well as ITGA6 were lost
during passage amplification, even if MSC retained mesenchymal phe-
notype. In agreement, we demonstrated that ITGA6 + cells had in-
creased CFE, supporting previous research (Lee et al., 2009; Yu et al.,
2012) and that a discrete reduction in ITGA6 expression can hinder
CFE. Cell size and progenitor potential are related in MSC, with smaller
cells showing enhanced potential for differentiation and rapid self-re-
newal (Colter et al., 2001). Our findings pointed out that ITGA6 + cells
Fig. 6. Implications of different substrates in BM-MSC behavior. (A) Cell proliferation assay by bromodeoxyuridine (BrdU) on laminin-111 (LN) and fibronectin (FN),
and plastic (Ctl). (B) Western blot analysis for p21, p27 and p53 and AKT on LN and FN. (C) Cell adhesion assay on extracellular matrix proteins LN, FN, bovine serum
albumin (BSA) and Ctl. (D) Expression of EGFR, TGF-β,MMP2 and IL-6mRNA in BM-MSC by qPCR on LN, FN and Ctl. (E) Cell adhesion assay on LN, FN and BSA with
(ITGA6 blocking) and without (IgG isotype) blockage on different substrates. (F) Percent of migrated cells trough transwells coated with LN and FN. Results are
presented as mean ± SE from 3 independent experiments. Statistical analysis was performed using two-tailed Student’s t-tests (*, p < 0.05; **, p < 0.01; ***,
p < 0.001).
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were smaller and had an increased differentiation capacity, supporting
the greater progenitor potential of this fraction. Our data suggests that
ITGA6 is regulated by an intrinsic program that indicates the progenitor
potential of each BM-MSC. So, ITGA6 could be a candidate for pre-
dicting MSC progenitor potential. Further, we confirmed that ITGA6
increased proliferation through AKT and cell cycle inhibitor proteins
p53, p27, and p21 agreeing with previous reports in umbilical cord
blood MSC (Yu et al., 2012).
MSC seeded at low density can increase progenitor gene expression
such as OCT4 and NANOG (Lee et al., 2013, 2009). In agreement, we
showed that ITGA6 expression decreased as confluency increased,
confirming the microenvironmental regulation of this integrin. So, the
decrease in proliferation in high confluent cultures was related to the
change in the expression of ITGA6 and the regulation of AKT pathway
and cell cycle inhibitor proteins, pointing out that the ITGA6 can act as
a proliferation regulator in response to culture confluence. ITGA6 was
expressed in cultures from ITGA6-cells, showing that lower confluences
can induce ITGA6 expression, further indicating the extrinsic modula-
tion of ITGA6 expression by culture confluence.
Levels of ITGA6 and CFE increased on cells grown for 1 day at low
Fig. 7. Stemness potential, proliferation and migration of ITGA6 + spheroid-derived MSC. (A) Expression of ITGA6 in spheroid-derived MSC by FACS analysis
compared to monolayer control cells (Ctl) and isotype negative controls (Neg). (B) Colony forming efficiency (CFE). (C) Transwell migration assay using calcein
staining and the percent of migrated spheroid-derived MSC (Bar = 50 μm). (D) Spheroid-derived MSC proliferation capability by bromodeoxyuridine (BrdU)
incorporation assay. (E) Western blot analysis p27, PCNA and AKT cell signaling pathway in MSCm/p, MSCm and (Ctl). (F) Expression of SOX2 and OCT4 mRNA in
spheroid-derived MSC, spheroid and Ctl by qPCR. (G) Representative immunofluorescence micrographs for SOX2 and OCT4 in spheroid-derived MSC and Ctl
(Bar = 20 μm). Results are presented as mean ± SE from 3 independent experiments. Statistical analysis was performed using two-tailed Student’s t-tests (*,
p < 0.05; **, p < 0.01; ***, p < 0.001).
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confluence on fibronectin, though ITGA6 was more specific for laminin-
111 binding than fibronectin, which suggests that fibronectin could
favor progenitor potential in MSC at low densities in comparison with
laminin-111. Although, further research is needed to clarify the exact
mechanism through fibronectin could increase ITGA6 expression, there
was an improved BM-MSC proliferation on fibronectin by AKT activa-
tion and a decrease of cell cycle inhibitor proteins. More studies are
needed also to study the effects of other laminin isoforms, though la-
minin-111 increased proliferation through impaired expressions of cell
cycle inhibitor proteins, but not by AKT activation, which was in-
hibited. Overall, our data suggest a bilateral interplay between AKT
pathway and ITGA6 expression. So, our results from ITGA6 mechanistic
assays and substrate-seeding analyses indicate that AKT pathway acti-
vation can play a central role in ITGA6 expression, supporting previous
data (Yu et al., 2012). To note, MSC treatment with TGF-β increases
ITGA6 expression (Shangguan et al., 2012), which is consistent with
our results showing that TGF-β was only increased on fibronectin sub-
strates where ITGA6 was augmented. Moreover, EGFR is known to
activate the AKT signaling pathway (Garay et al., 2015; Huang et al.,
2013; Krampera et al., 2005; Tamama et al., 2006), expression that was
increased on fibronectin, where AKT signaling pathway was activated.
Moreover, the highest IL-6 expression was found also in fibronectin
substrates, and IL-6 acts as a growth factor for MSC which deficiency
decreases the MSC progenitors in vivo (Rodríguez et al., 2004). There-
fore, these results could provide new insights about ITGA6 regulation.
More studies are needed regarding MSC migration and homing
(Ullah et al., 2019). Here, we showed that when ITGA6 decreased or
was functionally inhibited, migration of BM-MSC was impaired. This is
consistent with previous in vivo reports showing that ITGA6 blockade
reduces the homing of hematopoietic progenitors to the bone marrow
(Qian et al., 2006). Also, PODXLhi/ITGA6hi MSC population increased
cell migration toward an infarcted heart in mice (Lee et al., 2009). So,
we can posit that changes in the migration results induced by low
confluence and high confluence cultures are mediated, at least in part,
by ITGA6.
The spheroid microenvironment can enrich a culture in progenitor
stem cells (Zhang et al., 2015). The generation of spheroids is mediated
by ITGA6 through increases in OCT4 and SOX2, which control its
transcriptional regulation (Yu et al., 2012). Here, we showed that these
increases can be comparable to the expression levels of these factors in
IPSC, suggesting a high increase of the progenitor potential, since these
factors are central core players in maintaining self-renewal and plur-
ipotency (Rizzino, 2013). We also showed that spheroid-derived MSC
retained, to some extent, augmentation of these pluripotency markers
compared with controls, although NANOG was downregulated. How-
ever, NANOG is not essential to maintain multipotency (Marthaler
et al., 2016). So, the increase of SOX2 and OCT4 in spheroid-derived
MSC was translated into increased ITGA6 expression, higher CFE, a
greater proliferation and improved migration results. Such an approach
could enhance the potential of BM-MSC and could be used in vitro to
increase their therapeutic efficacy for clinical application.
5. Conclusions
Our results point out that although there is an intrinsic program
regulating the expression of ITGA6, which can indicate the progenitor
potential of BM-MSC, specific culture conditions and extracellular ma-
trix proteins modulate ITGA6 expression. This affects the proliferation,
through AKT signaling pathway and cell cycle inhibitor proteins, as
well as CFE and migration. These conditions could be used to enhance
the progenitor potential of MSC in cell therapy approaches.
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